CD8A and neoplasm: In TNBC models, G47Δ-mIL12, an engineered oncolytic virus expressing IL-12, suppressed tumor growth and prevented metastasis by enhancing APC activation, increasing CD8+ T cell infiltration, and reducing MDSCs [265].